9 months ago
KRYS
AnalystsGeulah LivshitsGeulah Livshits's Stock Forecasts
AnalystsGeulah Livshits
Sectors:
Industries:
Analyst Ranking
Top 5%
#197 out of 4575 analysts
Average Return
+20.9%
Win Rate
41%54 out of 131
Risk vs Reward
Poor
Good
Geulah Livshits's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cabaletta Bio IncCABA | +790.20% | $1.53 | $13.62 | 2022-08-11 - 2023-08-11 | Strong Buy |
Cabaletta Bio IncCABA | +651.26% | $2.38 | $17.88 | 2022-11-10 - 2023-11-10 | Strong Buy |
Provention Bio IncPRVB | +466.44% | $4.41 | $24.98 | 2022-08-04 - 2023-04-27 | Strong Buy |
Logicbio Therapeutics IncLOGC | +444.74% | $0.38 | $2.07 | 2022-08-21 - 2022-11-15 | Strong Buy |
Logicbio Therapeutics IncLOGC | +387.06% | $0.43 | $2.07 | 2022-05-16 - 2022-11-15 | Strong Buy |
Geulah Livshits Analyst Color
Get additional color on Geulah Livshits's coverage of popular stocks
10 months ago
FDMT
a year ago
KRYS
a year ago
IMRX
a year ago
MRNA
2 years ago
RCKT
Geulah Livshits's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Prime Medicine IncPRME | 1 | Strong Buy | $17.00 | +214.81% | Initiates Coverage On | 16 days ago |
Achilles Therapeutics PLCACHL | 5 | Strong Buy | $6.00 | +622.89% | Maintains | a month ago |
Metagenomi IncMGX | 2 | Strong Buy | $21.00 | +224.57% | Maintains | a month ago |
Tenaya Therapeutics IncTNYA | 7 | Strong Buy | $20.00 | +340.53% | Reiterates | 2 months ago |
Taysha Gene Therapies IncTSHA | 8 | Strong Buy | $7.00 | +167.18% | Maintains | 2 months ago |
Immuneering CorpIMRX | 6 | Strong Buy | $16.00 | +869.70% | Maintains | 2 months ago |
Crispr Therapeutics AgCRSP | 9 | Strong Buy | $112.00 | +96.28% | Maintains | 3 months ago |
Iovance Biotherapeutics IncIOVA | 10 | Strong Buy | $34.00 | +144.96% | Maintains | 3 months ago |
Lexeo Therapeutics IncLXEO | 1 | Strong Buy | $23.00 | +74.11% | Initiates Coverage On | 5 months ago |
Senti Biosciences IncSNTI | 5 | Strong Buy | $6.00 | +1,438.46% | Reiterates | 9 months ago |
Rocket Pharmaceuticals IncRCKT | 9 | Strong Buy | $61.00 | +162.93% | Reiterates | 9 months ago |
4d Molecular Therapeutics IncFDMT | 3 | Strong Buy | $31.00 | +15.84% | Reiterates | 9 months ago |
Meiragtx Holdings PLCMGTX | 4 | Strong Buy | $41.00 | +709.48% | Reiterates | 9 months ago |
Century Therapeutics IncIPSC | 3 | Strong Buy | $17.00 | +436.28% | Maintains | 9 months ago |
Krystal Biotech IncKRYS | 5 | Strong Buy | $153.00 | -2.51% | Maintains | 9 months ago |
Passage Bio IncPASG | 2 | Strong Buy | $9.00 | +538.30% | Maintains | 9 months ago |
Intellia Therapeutics IncNTLA | 10 | Strong Buy | $107.00 | +351.10% | Reiterates | 9 months ago |
Editas Medicine IncEDIT | 7 | Strong Buy | $19.00 | +235.69% | Maintains | 9 months ago |
Immatics NvIMTX | 2 | Strong Buy | $25.00 | N/A | Maintains | a year ago |
Cabaletta Bio IncCABA | 4 | Strong Buy | $12.00 | N/A | Reiterates | a year ago |
Provention Bio IncPRVB | 4 | Strong Buy | $25.00 | N/A | Maintains | a year ago |
Moderna IncMRNA | 7 | Hold | $208.00 | N/A | Maintains | a year ago |
Sqz Biotechnologies CoSQZB | 3 | Strong Buy | $4.00 | N/A | Maintains | a year ago |
Pds Biotechnology CorpPDSB | 3 | Strong Buy | $16.00 | N/A | Maintains | a year ago |
Logicbio Therapeutics IncLOGC | 4 | Strong Buy | $2.50 | N/A | Maintains | 2 years ago |
Solid Biosciences IncSLDB | 3 | Strong Buy | $90.00 | N/A | Maintains | 2 years ago |
Q32 Bio IncQTTB | 2 | Strong Buy | $270.00 | N/A | Maintains | 2 years ago |
Regenxbio IncRGNX | 1 | Strong Buy | $90.00 | N/A | Maintains | 3 years ago |
Voyager Therapeutics IncVYGR | 1 | Hold | $4.00 | N/A | Maintains | 3 years ago |
Renovacor IncRCOR | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 3 years ago |
Vincerx Pharma IncVINC | 2 | Strong Buy | $30.00 | N/A | Maintains | 3 years ago |
Adverum Biotechnologies IncADVM | 1 | Hold | $30.00 | N/A | Maintains | 3 years ago |
Immunome IncIMNM | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.